Amsbio reports how researchers from the Karolinska Institute, Stockholm, Sweden are using their Adeno Associated Virus (AAV) products in a groundbreaking investigation into the causes of Rheumatoid Arthritis pain.
Quadram Institute Bioscience are looking for a Director of Operations to join our Directorate Department.
BIO-Europe is Europe’s largest and longest-running partnering conference for the global biotechnology and biopharma industry. The event brings together 5800+ from more than 3,200 companies across 60+ countries, to build partnerships, share insights, and explore business opportunities in life sciences.
Through partnership with One Nucleus partners, EBD Group, One Nucleus looks forward to supporting our members again this year at BIO-Europe 202.
HBA CAMBRIDGE PRESENTS
Empowering Change in Healthcare: HBA Cambridge Innovation Leadership Forum
On 21st May 2026, join HBA Cambridge and leaders from across Cambridge and the UK for an inspiring, thought-provoking forum exploring how innovation, collaboration, and representative leadership are redefining the life sciences. The event will take place at Homerton College from 9:45 AM to 5:00 PM.
o2h Discovery, a leading integrated drug discovery CRO, today announces the launch of the latest edition of o2h Kickstarter Award for Peptide, a dedicated programme/Award designed to support early-stage biotech companies advancing peptide-based therapeutics.
Expanding clinical trials into the EU and UK creates new opportunities for sponsors but also brings complex data protection and legal requirements.
Role Summary
AI hallucinations in drug discovery aren't just an AI problem — they're a data problem.
👉 52% of life science professionals say poor data quality is the #1 barrier to AI implementation
👉 27% of organisations can't even trace the evidence chain powering their AI systems.
In this new white-paper authored by Digital Science's Mark Hahnel we see the practical playbook: FAIR data principles, knowledge graphs, and neuro-symbolic AI for building a foundation pharma can actually trust.
Based in our Discovery Centre on the Cambridge Addenbrookes campus, this Senior Scientist role sits at the heart of Genetic Toxicology, working alongside colleagues in Clinical Pharmacology and Safety Sciences to advance the genotoxicity assessment of new medicines. The position focuses on high-throughput imaging and screening methodologies to generate robust, decision-enabling data that informs safety assessment across drug discovery and development.